U.K. reclassifies liquid paracetamol
This article was originally published in The Tan Sheet
Executive SummaryThe Medicines and Healthcare products Regulatory Agency increases the maximum strength of liquid paracetamol, marketed as acetaminophen in the U.S., available for general sale from 2.5 percent to 5 percent for use by adults and children over 12 years of age. Liquid paracetamol preparations previously could only be offered in general sale - the equivalent of OTC in the U.S. - in 2.5 percent solutions and consumers would have to buy 5 percent preparations from a pharmacist, the U.K. agency announces Aug. 21
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.